Literature DB >> 22661085

IL-33 priming regulates multiple steps of the neutrophil-mediated anti-Candida albicans response by modulating TLR and dectin-1 signals.

Hongnga T Le1, Vuvi G Tran, Wonyoung Kim, Juyang Kim, Hong R Cho, Byungsuk Kwon.   

Abstract

IL-33 is known to play an important role in Th2 immunity. In this study, we investigated the effect of IL-33 pretreatment on anti-fungal response using an acute Candida albicans peritoneal infection model. IL-33 pretreatment induced a rapid fungal clearance and markedly reduced the C. albicans infection-associated mortality. The priming effect of IL-33 occurred during multiple steps of the neutrophil-mediated anti-fungal response. First, the anti-fungal effect occurred due to the rapid and massive recruitment of neutrophils to the site of infection as a result of the release of CXCR2 chemokines by peritoneal macrophages and by reversal of the TLR-induced reduction of CXCR2 expression in neutrophils during IL-33 priming. Second, conditioning of neutrophils by IL-33 activated the TLR and dectin-1 signaling pathways, leading to the upregulation of complement receptor 3 expression induced by C. albicans. Upregulated CR3 in turn increased the phagocytosis of opsonized C. albicans and resulted in the production of high levels of reactive oxygen species and the subsequent enhanced killing activity of neutrophils. Taken together, our results suggest that IL-33 can regulate the anti-fungal activity of neutrophils by collaborative modulation of the signaling pathways of different classes of innate immune receptors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22661085     DOI: 10.4049/jimmunol.1103564

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  Thymic stromal lymphopoietin-induced interleukin-17A is involved in the development of IgE-mediated atopic dermatitis-like skin lesions in mice.

Authors:  Nobuaki Mizutani; Chutha Sae-Wong; Sureeporn Kangsanant; Takeshi Nabe; Shin Yoshino
Journal:  Immunology       Date:  2015-09-24       Impact factor: 7.397

2.  IL-33 induces immunosuppressive neutrophils via a type 2 innate lymphoid cell/IL-13/STAT6 axis and protects the liver against injury in LCMV infection-induced viral hepatitis.

Authors:  Yuejin Liang; Panpan Yi; Denley Ming Kee Yuan; Zuliang Jie; Zakari Kwota; Lynn Soong; Yingzi Cong; Jiaren Sun
Journal:  Cell Mol Immunol       Date:  2018-02-05       Impact factor: 11.530

3.  A novel function of IL-33: suppression of innate antiviral immunity.

Authors:  Akio Matsuda
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 4.  Pleiotropic regulations of neutrophil receptors response to sepsis.

Authors:  Huafeng Zhang; Bingwei Sun
Journal:  Inflamm Res       Date:  2016-09-30       Impact factor: 4.575

Review 5.  Neutrophils in innate and adaptive immunity.

Authors:  Sébastien Jaillon; Maria Rosaria Galdiero; Davide Del Prete; Marco Antonio Cassatella; Cecilia Garlanda; Alberto Mantovani
Journal:  Semin Immunopathol       Date:  2013-04-04       Impact factor: 9.623

6.  IL-33 enhances macrophage release of IL-1β and promotes pain and inflammation in gouty arthritis.

Authors:  Victor Fattori; Larissa Staurengo-Ferrari; Tiago H Zaninelli; Rubia Casagrande; Rene D Oliveira; Paulo Louzada-Junior; Thiago M Cunha; Jose C Alves-Filho; Mauro M Teixeira; Fernando Q Cunha; Flavio A Amaral; Waldiceu A Verri
Journal:  Inflamm Res       Date:  2020-09-04       Impact factor: 4.575

7.  IL-33 Signaling Regulates Innate IL-17A and IL-22 Production via Suppression of Prostaglandin E2 during Lung Fungal Infection.

Authors:  Jaleesa M Garth; Kristen M Reeder; Matthew S Godwin; Joseph J Mackel; Chad W Dunaway; Jonathan P Blackburn; Chad Steele
Journal:  J Immunol       Date:  2017-08-07       Impact factor: 5.422

8.  Cellular context of IL-33 expression dictates impact on anti-helminth immunity.

Authors:  Li-Yin Hung; Yukinori Tanaka; Karl Herbine; Christopher Pastore; Brenal Singh; Annabel Ferguson; Nisha Vora; Bonnie Douglas; Kelly Zullo; Edward M Behrens; Tiffany Li Hui Tan; Michael A Kohanski; Paul Bryce; Cailu Lin; Taku Kambayashi; Danielle R Reed; Breann L Brown; Noam A Cohen; De'Broski R Herbert
Journal:  Sci Immunol       Date:  2020-11-13

Review 9.  Interleukin-33 in health and disease.

Authors:  Foo Yew Liew; Jean-Philippe Girard; Heth Roderick Turnquist
Journal:  Nat Rev Immunol       Date:  2016-09-19       Impact factor: 53.106

Review 10.  IL-33 in obesity: where do we go from here?

Authors:  Marcos Felipe Andrade de Oliveira; André Talvani; Etel Rocha-Vieira
Journal:  Inflamm Res       Date:  2019-01-17       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.